Showing results (41-50 of 927) with videos related to
Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|September 21, 2015
Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects studyCatherine Keating, Martin Neovius, Kajsa Sjöholm, et al.The Lancet. Diabetes & Endocrinology|September 22, 2015
Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control studyAnnika Rosengren, Daniel Vestberg, Ann-Marie Svensson, et al.The Lancet. Diabetes & Endocrinology|August 4, 2015
Association of age and BMI with kidney function and mortality: a cohort studyJun Ling Lu, Miklos Z Molnar, Adnan Naseer, et al.The Lancet. Diabetes & Endocrinology|January 19, 2016
Gradual reduction of sugar in soft drinks without substitution as a strategy to reduce overweight, obesity, and type 2 diabetes: a modelling studyYuan Ma, Feng J He, Yunjian Yin, et al.The Lancet. Diabetes & Endocrinology|January 20, 2016
Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysisJon White, Reecha Sofat, Gibran Hemani, et al.The Lancet. Diabetes & Endocrinology|September 15, 2015
Type 2 diabetes and the skeleton: new insights into sweet bonesVikram V Shanbhogue, Deborah M Mitchell, Clifford J Rosen, et al.The Lancet. Diabetes & Endocrinology|October 27, 2015
Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort studyTim I M Korevaar, Ryan Muetzel, Marco Medici, et al.The Lancet. Diabetes & Endocrinology|February 27, 2016
Shared decision making in endocrinology: present and future directionsRene Rodriguez-Gutierrez, Michael R Gionfriddo, Naykky Singh Ospina, et al.The Lancet. Diabetes & Endocrinology|February 13, 2016
Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient dataNaveed Sattar, David Preiss, Jennifer G Robinson, et al.The Lancet. Diabetes & Endocrinology|February 16, 2016
The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventionsMichael A Nauck, Juris J MeierPageof 93